|
A novel early cancer detection approach for pancreatic cancer. |
|
|
No Relationships to Disclose |
|
Patrick Christian Strasser |
|
|
Stock and Other Ownership Interests - Wholomics (I) |
Consulting or Advisory Role - Ever Neuro Pharma (Inst) |
Research Funding - Wholomics |
Patents, Royalties, Other Intellectual Property - Wholomics GmbH (Inst) |
Travel, Accommodations, Expenses - Wholomics |
Other Relationship - Whitehead Institute; Wholomics |
(OPTIONAL) Uncompensated Relationships - Wholomics |
|
Maximilian Christoph Schneider |
Employment - Ever Neuro Pharma (I); Novogenia; Wholomics |
Leadership - Ever Neuro Pharma (I) |
Stock and Other Ownership Interests - Ever Neuro Pharma (I); Wholomics |
Honoraria - Ever Neuro Pharma (I) |
Consulting or Advisory Role - Ever Neuro Pharma (I); Ever Neuro Pharma (Inst) |
Research Funding - Wholomics |
Patents, Royalties, Other Intellectual Property - Wholomics GmbH (Inst) |
Travel, Accommodations, Expenses - Ever Neuro Pharma (I); Wholomics |
Other Relationship - Wholomics |
(OPTIONAL) Uncompensated Relationships - Wholomics |
|
|
No Relationships to Disclose |